331 related articles for article (PubMed ID: 35018468)
1. Comprehensive analysis of prime editing outcomes in human embryonic stem cells.
Habib O; Habib G; Hwang GH; Bae S
Nucleic Acids Res; 2022 Jan; 50(2):1187-1197. PubMed ID: 35018468
[TBL] [Abstract][Full Text] [Related]
2. Highly efficient generation of isogenic pluripotent stem cell models using prime editing.
Li H; Busquets O; Verma Y; Syed KM; Kutnowski N; Pangilinan GR; Gilbert LA; Bateup HS; Rio DC; Hockemeyer D; Soldner F
Elife; 2022 Sep; 11():. PubMed ID: 36069759
[TBL] [Abstract][Full Text] [Related]
3. Adenine base editing reduces misfolded protein accumulation and toxicity in alpha-1 antitrypsin deficient patient iPSC-hepatocytes.
Werder RB; Kaserman JE; Packer MS; Lindstrom-Vautrin J; Villacorta-Martin C; Young LE; Aratyn-Schaus Y; Gregoire F; Wilson AA
Mol Ther; 2021 Nov; 29(11):3219-3229. PubMed ID: 34217893
[TBL] [Abstract][Full Text] [Related]
4. Transient inhibition of p53 enhances prime editing and cytosine base-editing efficiencies in human pluripotent stem cells.
Li M; Zhong A; Wu Y; Sidharta M; Beaury M; Zhao X; Studer L; Zhou T
Nat Commun; 2022 Oct; 13(1):6354. PubMed ID: 36302757
[TBL] [Abstract][Full Text] [Related]
5. Efficient Generation and Correction of Mutations in Human iPS Cells Utilizing mRNAs of CRISPR Base Editors and Prime Editors.
Sürün D; Schneider A; Mircetic J; Neumann K; Lansing F; Paszkowski-Rogacz M; Hänchen V; Lee-Kirsch MA; Buchholz F
Genes (Basel); 2020 May; 11(5):. PubMed ID: 32384610
[TBL] [Abstract][Full Text] [Related]
6. Enhancing genome editing in hPSCs through dual inhibition of DNA damage response and repair pathways.
Park JC; Kim YJ; Hwang GH; Kang CY; Bae S; Cha HJ
Nat Commun; 2024 May; 15(1):4002. PubMed ID: 38734692
[TBL] [Abstract][Full Text] [Related]
7. Prime editing for functional repair in patient-derived disease models.
Schene IF; Joore IP; Oka R; Mokry M; van Vugt AHM; van Boxtel R; van der Doef HPJ; van der Laan LJW; Verstegen MMA; van Hasselt PM; Nieuwenhuis EES; Fuchs SA
Nat Commun; 2020 Oct; 11(1):5352. PubMed ID: 33097693
[TBL] [Abstract][Full Text] [Related]
8. A robust and inducible precise genome editing via an all-in-one prime editor in human pluripotent stem cells.
Wu Y; Zhong A; Sidharta M; Kim TW; Ramirez B; Persily B; Studer L; Zhou T
bioRxiv; 2024 Jan; ():. PubMed ID: 38293122
[TBL] [Abstract][Full Text] [Related]
9. Prime Editing: An Emerging Tool in Cancer Treatment.
Sen D; Sarkar S; Mukhopadhyay P
Mol Biotechnol; 2023 Apr; 65(4):509-520. PubMed ID: 36251123
[TBL] [Abstract][Full Text] [Related]
10. Targeting specificity of APOBEC-based cytosine base editor in human iPSCs determined by whole genome sequencing.
McGrath E; Shin H; Zhang L; Phue JN; Wu WW; Shen RF; Jang YY; Revollo J; Ye Z
Nat Commun; 2019 Nov; 10(1):5353. PubMed ID: 31767844
[TBL] [Abstract][Full Text] [Related]
11. Protocol for the design, conduct, and evaluation of prime editing in human pluripotent stem cells.
Wu Y; Sidharta M; Zhong A; Persily B; Li M; Zhou T
STAR Protoc; 2023 Dec; 4(4):102583. PubMed ID: 37738119
[TBL] [Abstract][Full Text] [Related]
12. Engineered pegRNAs improve prime editing efficiency.
Nelson JW; Randolph PB; Shen SP; Everette KA; Chen PJ; Anzalone AV; An M; Newby GA; Chen JC; Hsu A; Liu DR
Nat Biotechnol; 2022 Mar; 40(3):402-410. PubMed ID: 34608327
[TBL] [Abstract][Full Text] [Related]
13. Mutation-specific reporter for optimization and enrichment of prime editing.
Schene IF; Joore IP; Baijens JHL; Stevelink R; Kok G; Shehata S; Ilcken EF; Nieuwenhuis ECM; Bolhuis DP; van Rees RCM; Spelier SA; van der Doef HPJ; Beekman JM; Houwen RHJ; Nieuwenhuis EES; Fuchs SA
Nat Commun; 2022 Mar; 13(1):1028. PubMed ID: 35232966
[TBL] [Abstract][Full Text] [Related]
14. Improved prime editors enable pathogenic allele correction and cancer modelling in adult mice.
Liu P; Liang SQ; Zheng C; Mintzer E; Zhao YG; Ponnienselvan K; Mir A; Sontheimer EJ; Gao G; Flotte TR; Wolfe SA; Xue W
Nat Commun; 2021 Apr; 12(1):2121. PubMed ID: 33837189
[TBL] [Abstract][Full Text] [Related]
15. A selectable all-in-one CRISPR prime editing piggyBac transposon allows for highly efficient gene editing in human cell lines.
Eggenschwiler R; Gschwendtberger T; Felski C; Jahn C; Langer F; Sterneckert J; Hermann A; Lühmann J; Steinemann D; Haase A; Martin U; Petri S; Cantz T
Sci Rep; 2021 Nov; 11(1):22154. PubMed ID: 34773059
[TBL] [Abstract][Full Text] [Related]
16. In vivo somatic cell base editing and prime editing.
Newby GA; Liu DR
Mol Ther; 2021 Nov; 29(11):3107-3124. PubMed ID: 34509669
[TBL] [Abstract][Full Text] [Related]
17. Genomic and Transcriptomic Analyses of Prime Editing Guide RNA-Independent Off-Target Effects by Prime Editors.
Gao R; Fu ZC; Li X; Wang Y; Wei J; Li G; Wang L; Wu J; Huang X; Yang L; Chen J
CRISPR J; 2022 Apr; 5(2):276-293. PubMed ID: 35294852
[TBL] [Abstract][Full Text] [Related]
18. Broadening prime editing toolkits using RNA-Pol-II-driven engineered pegRNA.
Huang S; Zhang Z; Tao W; Liu Y; Li X; Wang X; Harati J; Wang PY; Huang X; Lin CP
Mol Ther; 2022 Sep; 30(9):2923-2932. PubMed ID: 35799444
[TBL] [Abstract][Full Text] [Related]
19. In Vivo Genome Editing Partially Restores Alpha1-Antitrypsin in a Murine Model of AAT Deficiency.
Song CQ; Wang D; Jiang T; O'Connor K; Tang Q; Cai L; Li X; Weng Z; Yin H; Gao G; Mueller C; Flotte TR; Xue W
Hum Gene Ther; 2018 Aug; 29(8):853-860. PubMed ID: 29597895
[TBL] [Abstract][Full Text] [Related]
20. An engineered prime editor with enhanced editing efficiency in plants.
Zong Y; Liu Y; Xue C; Li B; Li X; Wang Y; Li J; Liu G; Huang X; Cao X; Gao C
Nat Biotechnol; 2022 Sep; 40(9):1394-1402. PubMed ID: 35332341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
